Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-19

Clinical Trial Update: Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating different doses of vitamin E for treatment of fatty liver disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin E (tocopherol)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Fatty Liver | Phase 2 | Status: COMPLETED | Results posted: 2020-10-19